Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Endometriosis peptide trials
4 selected ClinicalTrials.gov records carrying the official condition label Endometriosis. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
4 selected records.
4 profiles.
2008–2024 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 107 selected PubMed records and 14 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Endometriosis unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT00034047
PeptideScanner retained ClinicalTrials.gov record NCT00034047 at 2026-11-16T01:35:57.709Z. Its registry update date was 2008-01-25, and PeptideScanner's reviewed identity mapping was nafarelin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- January 25, 2008
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00244452
PeptideScanner retained ClinicalTrials.gov record NCT00244452 at 2026-11-15T22:02:39.332Z. Its registry update date was 2008-03-31, and PeptideScanner's reviewed identity mapping was cetrorelix.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- March 31, 2008
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01682642
PeptideScanner retained ClinicalTrials.gov record NCT01682642 at 2026-11-15T21:50:32.222Z. Its registry update date was 2015-03-20, and PeptideScanner's reviewed identity mapping was goserelin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- March 20, 2015
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Triptorelin · 2024-07-10
ClinicalTrials.gov record NCT02400801
Completed at the retained observation.
Open attributed record →Goserelin · 2015-03-20
ClinicalTrials.gov record NCT01682642
Completed at the retained observation.
Open attributed record →Cetrorelix · 2008-03-31
ClinicalTrials.gov record NCT00244452
Completed at the retained observation.
Open attributed record →Nafarelin · 2008-01-25
ClinicalTrials.gov record NCT00034047
Completed at the retained observation.
Open attributed record →